Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by canadapieton Dec 06, 2019 11:11am
94 Views
Post# 30428991

RE:RE:RE:RE:RE:RE:RE:I am getting envious

RE:RE:RE:RE:RE:RE:RE:I am getting enviousMr. SPCEO1, 

with all due respect, but i don't understand being such a large shareholder 
and letting things go the (wrong) way without asking (many) questions!!
You are a loyal shareholder but i have the impression that the BOD is not that 
loyal to you (and us)!!! 
What a mega-difference with other companies! 
I stand fully behind mister Wino's questions and it is time the BOD/
Management make things clearer for the shareholders. They clearly don't 
have respect for them, otherwise they would dare to interfere with them!! 


Succes!! 

SPCEO1
 - (12/6/2019 10:54:47 AM) 
RE:RE:RE:RE:RE:RE:I am getting envious
Thanks Wino for the thoughtful questions and all the good work you have done for us here. I have not decided if I am even going to approach Dawn with any of this yet, though. We are about as friendly a shareholder as a company can get and I feel like I get good answers most of the time from management and don't want to or need to go over their head to the board. Now, the current situation is pretty extreme with regard to the share price and makes so little sense, so maybe it would be good to set up a meeting with Dawn. I am still thinking about that but if I had to decide right now, I would lkely not try to schedule a meeting. I am not sure how much more stock our seller has to sell but once that is out of the way, I expect order will likely be restored in the share price pretty quickly. And since Dawn and other board members own shares of the company as well, I think they are very much aware of what is going on and are likely thinking hard about what to do about it. Since we don't hear from the board, we assume they are out of touch with what si going on, but I don't believe that is not the case.  
Bullboard Posts